Cell Culture Market by Product (Consumables (Media, Serum, Reagent, Vessels), Equipment (Bioreactor, Centrifuge, Incubator)), Application (Vaccines, mAbs, Diagnostics, Tissue Engineering), End User (Pharma, Biotech, Hospital) - Global Forecast to 2026" The global cell culture market is projected to reach USD 41.3 billion by 2026 from USD 22.8 billion in 2021, at a CAGR of 12.6 % between 2021 and 2026. The growth of this market is majorly driven by the growing awareness about the benefits of cell-based vaccines, increasing demand for monoclonal antibodies (mAbs), funding for cell-based research, growing preference for single-use technologies, the launch of advanced cell culture products, and the growing focus on personalized medicine. On the other hand, the high cost of cell biology research is restraining the growth of this market.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=559
Browse in-depth TOC on "Cell Culture Market”
257 – Tables
57 – Figures
296 – Pages
Key Player
Key players in the Cell Culture Market include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany).
Thermo Fisher Scientific (US) offers cell culture products such as consumables, instruments, and equipment through three segments—Life Sciences Solutions, Specialty Diagnostics, and Laboratory Products & Services. The company has a strong geographic footprint and operates in more than 150 countries across North America, Europe, Latin America, and Asia. From 2019 to 2021, Thermo Fisher Scientific launched 8 cell culture products, including cell culture media, cultureware, and equipment. With its strong product portfolio, continuous research and development activities, and broad geographic reach, Thermo Fisher Scientific is expected to witness significant growth in the global cell culture market.
Danaher Corporation (US) conducts its business through three segments, namely, Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences business segment of Danaher offers products under the brands of Cytiva, Pall Corporation, Beckman Coulter, and Leica Microsystems. The company has a strong geographic presence through subsidiaries across North America, Europe, the Asia Pacific, Latin America, and Africa. The company has launched 4 products in the cell culture market since 2020. Danaher also has a significant focus on strategic collaborations and acquisitions to strengthen its competitive position in the cell culture market.
Merck KGaA (Germany) provides cell culture separation and purification tools through its Research Solutions subsegment, single-use manufacturing and filtration products through its Process Solutions subsegment, and lab water and microbiology solutions through its Applied Solutions subsegment. The company primarily focuses on expansions to strengthen its position in this market. For instance, in March 2021, Merck KGaA established a single-use assembly production unit worth USD 45.8 million at its Life Science Center for Single-use Products Critical to Manufacturing Vaccines and Lifesaving Therapies. In December 2020, Merck KGaA invested USD 45.7 million to increase its production capacity for lifesaving therapies, including COVID-19 vaccines, products, and services for biopharmaceutical manufacturing.
Request Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=559
Recent Developments:
- In October 2021, Thermo Fisher Scientific Inc. (US) launched the Gibco Cell Therapy Systems (CTS) NK-Xpander Medium, which supports the large-scale growth and culture of functional natural killer (NK) cells with or without the use of feeder cells.
- In September 2021, Cytiva expanded its manufacturing capacity for bioprocessing single-use consumables by launching 3 new manufacturing facilities in under ten months.
The Asia Pacific region is the fastest-growing region of the cell culture market in 2020.
Based on the region, the global cell culture market has been segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The Asia Pacific market is estimated to register the highest CAGR during the forecast period. Government initiatives for research on stem cell therapy, growing geriatric population, the rising prominence of regenerative medicine research, increasing number of researchers in Japan, growth of preclinical/clinical research in China, favorable changes in foreign direct investment (FDI) regulations in the pharmaceutical industry in India, and growth of the pharmaceutical & biopharmaceutical sectors in South Korea are the major factors contributing to the growth of the cell culture market in the Asia Pacific.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=559
Browse Adjacent Market: 3D Bioprinting Market Research Reports & Consulting
Related Reports:
laboratory-equipment-service-market by Type (Repair & Maintenance, Calibration, Validation), Contract (Standard, Custom), Equipment (Analytical, Equipment, General, Support), Service Provider (OEM), and End User (Pharmaceutical) - Global Forecast to 2024
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/cell-culture-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/cell-culture.asp
Related Reports:
Patient Engagement Technology Market
Surgical Instrument Tracking Systems Market